U.S. Researchers are Investigating an Oral Flu Vaccine

According to a recent article in MD Magazine, scientists at a private research company have made significant progress toward the development of an oral flu vaccine. As stated in the article, the researchers at Vaxart, Inc., “have found that an oral tablet for influenza vaccination can protect against infection just as well as – if not better than – a commercial injectable quadrivalent influenza vaccine.”

The oral flu vaccine recently underwent Phase 2 clinical trials, reportedly with very favorable results. MD Magazine reports that: Continue reading

Immunization Works is the CDC’s Monthly Vaccine Newsletter

Each month, the Centers for Disease Control and Prevention (CDC) publish a newsletter highlighting recent news and updates in the world of immunizations. The CDC provides this newsletter, titled Immunization Works, to “national health care provider and consumer groups for distribution to their members and constituencies.” However, it is also free to the public online. Continue reading

Could Vaccines Cure Cancer? Early Trials Show Potential Application for Melanoma

According to a recent article in Medical News Today, “Scientists have developed a new vaccine that — in conjunction with existing therapies — can not only treat aggressive melanoma, but also prevent its recurrence.” The research is being performed at the Scripps Research Institute in San Diego, and the complete results of the latest study have been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS). Continue reading